期刊文献+

免疫因素及cccDNA与HBV的持续感染 被引量:1

Immunology and cccDNA in hepatitis B virus persistence
原文传递
导出
摘要 由于乙肝疫苗普遍接种,乙型肝炎的流行已经下降,但慢性乙型肝炎(CHB)仍是严重的全球性公共卫生问题。超螺旋共价闭合环状DNA(cccDNA)作为原始转录模板,逃避机体免疫及抗病毒药物清除,在HBV持续感染中发挥重要作用。基于调节患者对HBV的免疫功能研究新的治疗策略以清除细胞核内cccDNA可能成为根除HBV持续感染的途径。 Since the introduction of hepatitis B vaccine,the worldwide prevalence of hepatitis B infection has fallen. However,chronic infection remains a global health challenge. HBV covalently closed circular DNA( cccDNA)plays a key role in the persistence of the infection,as the transcriptional template it's very stable in quiescent hepatocytes. Development of new drugs and strategies to improve antiviral immunity and depletion of the cccDNA reservoir may eradicate persistent HBV infection
出处 《中国微生态学杂志》 CAS CSCD 2014年第9期1111-1115,共5页 Chinese Journal of Microecology
基金 兰州大学第二医院科研项目(YJ2010-09)
关键词 乙型肝炎病毒 慢性乙型肝炎 免疫 CCCDNA Hepatitis B virus Chronic hepatitis B Immunology cccDNA
  • 相关文献

参考文献47

  • 1Liaw YF, Chu CM. Hepatistis B virus infection[ J]. Lancet, 2009, 373(9663) : 582-592.
  • 2Ganem D, Prine AM. Hepatitis B virus infection-natural history and clinical consequences [ J ]. N Engl J Med, 2004, 350 ( 11 ) : 1118- 1129.
  • 3Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection[J]. Hepatology, 2003, 38 (5) : 1075-1086.
  • 4Dandri M, Burda MR, Will H, et al. Increased hepatocyte turn- over and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA [J].Hepatology, 2000, 32(1): 139-146.
  • 5Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis [ J ]. Annu Rev Pathol, 2006, 1 : 23-61 ( ISSN : 1553- 4006).
  • 6Liaw YF. Asia-Pacific Pocket Guide to Hepatitis B [ M ]. New Jersey: University of Wisconsin Board of Regents and MDG Development Group, 2006.
  • 7Lee CM, Ong GY, Lu SN, et al. Durability of lamivudine induced HBeAg for chronic hepatitis B patients with acute ex- acerbation[J].J Hepatol, 2002, 37(5): 669-674.
  • 8Caeciola I, Pollicino T, Squadrito G, et al. Quantification of intra- hepatic hepatisis B virus DNA(HBV) in patients with chronic HBV infection[J]. Hepatology, 2000, 31(2) : 507-512.
  • 9陈瀑,史静,邹麟.HBsAg定量检测在慢性乙型肝炎自然病程中的意义[J].中国微生态学杂志,2013,25(8):928-930. 被引量:7
  • 10Tsiang M, Rooney JF, Toole JJ, et al. Biphasie clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy [J]. Hepatology, 1999, 29(6) : 1863-1869.

二级参考文献20

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2周友乾,尹凤鸣,冯经华.干扰素治疗慢性乙型病毒性肝炎疗效的预测分析[J].华南国防医学杂志,2007,21(1):20-22. 被引量:6
  • 3CHEONG J Y. Management of chronic hepatitis B in treatment-naive patients[ J]. Korean J Gastroenterol,2008,51:338-345.
  • 4COOKSLEY W G, PIRATVISUTH T, LEE S D, et al. Peginterferonα-2a (40 kDa) : an advance in the treatment of hepatitis B e antigen-posi- tive chronic hepatitis B [ J ]. J Viral Hepatitis, 2003, 10 (4) :298-305.
  • 5CHAN H L,WONG V W,CHIM A M,et al. Treatment of patients with chronic hepatitis B who have failed previous antiviral treatment with pe- gylated interferon alpha-2a [ J ]. Antiviral therapy, 2008,13 ( 4 ) : 555- 562.
  • 6PISIT T, PIYAWAT K, VAROCHA M, et al. Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hep- atitis B virus DNA levels for predicting virological response to pegylated interferon-a-2b therapy in hepatitis B e-antigen-positive chronic hepati- tis B[ J]. Hepatol Res ,2010,40:269-277. h.
  • 7BORG M J,HANSEN B E,BIGOT G,et al. ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepati- tis B[J]. J Clin Virol ,2008 ,42 :160-164.
  • 8LOK A S,HEATHCOTE E J,HOOFNAGLE J H. Management of hepa- titis B:2000-summary of a workshop[J]. Gastroenterology,2001,120: 1828-1853.
  • 9Chan HL,Wong V,Wong GL, et al. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B[J]. Sepatology,2010,52(4) :1232-1241.
  • 10Mauro V, Pietro L. Clinical iImplications of HBsAg quantification in patients with chronic hepatitis B Saudi [ J ]. J Gastroenterol,2012,18 (2) :81-86.

共引文献8

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部